InvestorsHub Logo
Followers 44
Posts 10483
Boards Moderated 0
Alias Born 01/13/2016

Re: None

Tuesday, 02/16/2016 5:47:23 PM

Tuesday, February 16, 2016 5:47:23 PM

Post# of 470612
Anavex is pioneering the FIRST TREATMENT to actually show the possiblitiy of reversal of Neuronal Cell Damage by combining the Chaperone Sigma 1 Receptor and Muscsaric(?) ..and we are all not billionairres yet? go figure. People have been getting better for over a year, but that's not good enough? Possibly 3 new Phase 2/3 Studiesto BEGIN THIS YEAR..But not fast enough for all these Long Whiners? Maybe Retail gets what it deserves.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News